Organ engineering--combining stem cells, biomaterials, and bioreactors to produce bioengineered organs for transplantation.

Often the only treatment available for patients suffering from diseased and injured organs is whole organ transplant. However, there is a severe shortage of donor organs for transplantation. The goal of organ engineering is to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. Recent progress in stem cell biology, biomaterials, and processes such as organ decellularization and electrospinning has resulted in the generation of bioengineered blood vessels, heart valves, livers, kidneys, bladders, and airways. Future advances that may have a significant impact for the field include safe methods to reprogram a patient's own cells to directly differentiate into functional replacement cell types. The subsequent combination of these cells with natural, synthetic and/or decellularized organ materials to generate functional tissue substitutes is a real possibility. This essay reviews the current progress, developments, and challenges facing researchers in their goal to create replacement tissues and organs for patients.

[1]  Masayuki Yamato,et al.  Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. , 2009, Current pharmaceutical design.

[2]  C. Fong,et al.  Teratomas from pluripotent stem cells: A clinical hurdle , 2010, Journal of cellular biochemistry.

[3]  A. Consiglio,et al.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes , 2008, Nature Biotechnology.

[4]  Deepak M. Gupta,et al.  Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells , 2009, Proceedings of the National Academy of Sciences.

[5]  P. Taupin The therapeutic potential of adult neural stem cells. , 2006, Current opinion in molecular therapeutics.

[6]  Naoko Nakamura,et al.  Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays. , 2012, Cellular reprogramming.

[7]  Maya Schuldiner,et al.  Induced neuronal differentiation of human embryonic stem cells , 2001, Brain Research.

[8]  M. Conconi,et al.  Tracheal matrices, obtained by a detergent‐enzymatic method, support in vitro the adhesion of chondrocytes and tracheal epithelial cells , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[9]  S. Soker,et al.  The use of thermal treatments to enhance the mechanical properties of electrospun poly(ɛ-caprolactone) scaffolds , 2008 .

[10]  D. Mooney,et al.  Alginate: properties and biomedical applications. , 2012, Progress in polymer science.

[11]  Pedro M. Baptista,et al.  The use of whole organ decellularization for the generation of a vascularized liver organoid , 2011, Hepatology.

[12]  Anthony Atala,et al.  Bioreactor maintained living skin matrix. , 2009, Tissue engineering. Part A.

[13]  J. Itskovitz‐Eldor,et al.  Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1 , 2004, Biology of reproduction.

[14]  R. Timpl,et al.  Immunochemistry of collagens and procollagens. , 1976, International review of connective tissue research.

[15]  A. Atala,et al.  Acellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair. , 1999, Urology.

[16]  A. Atala,et al.  Tissue engineered stents created from chondrocytes. , 2001, The Journal of urology.

[17]  M. Matthay,et al.  Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors , 2011, Stem cells.

[18]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[19]  A. Atala Autologous cell transplantation for urologic reconstruction. , 1998, The Journal of urology.

[20]  Robert Langer,et al.  Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.

[21]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[22]  Jason A. Burdick,et al.  Hyaluronic Acid Hydrogels for Biomedical Applications , 2011, Advanced materials.

[23]  James A. Thomson,et al.  Hematopoietic colony-forming cells derived from human embryonic stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Itskovitz‐Eldor,et al.  Insulin production by human embryonic stem cells. , 2001, Diabetes.

[25]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[26]  S. Soker,et al.  Chondrogenic differentiation of amniotic fluid-derived stem cells , 2007, Journal of Molecular Histology.

[27]  A. Atala,et al.  Creation Of Functional Kidney Structures With Excretion Of Urine-like Fluid In Vivo , 1996 .

[28]  Staffan Strömblad,et al.  RETRACTED: Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study , 2011, The Lancet.

[29]  Sean Murphy,et al.  Amnion epithelial cell isolation and characterization for clinical use. , 2010, Current protocols in stem cell biology.

[30]  T. Enver,et al.  Forcing cells to change lineages , 2009, Nature.

[31]  R Langer,et al.  Creation of viable pulmonary artery autografts through tissue engineering. , 1998, The Journal of thoracic and cardiovascular surgery.

[32]  N. Hibino,et al.  Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. , 2001, Tissue engineering.

[33]  Anthony Atala,et al.  Oxygen producing biomaterials for tissue regeneration. , 2007, Biomaterials.

[34]  H. Sieburg,et al.  Deterministic regulation of hematopoietic stem cell self-renewal and differentiation. , 2002, Blood.

[35]  G. Daley,et al.  Generation of induced pluripotent stem cells from human blood. , 2009, Blood.

[36]  A. Atala,et al.  Bladder augmentation using allogenic bladder submucosa seeded with cells. , 1998, Urology.

[37]  J. O'grady,et al.  Global regulatory registration requirements for collagen-based combination products: points to consider. , 2003, Advanced drug delivery reviews.

[38]  H. Clevers,et al.  Stem cells, self-renewal, and differentiation in the intestinal epithelium. , 2009, Annual review of physiology.

[39]  P. McFetridge,et al.  A mechanical evaluation of three decellularization methods in the design of a xenogeneic scaffold for tissue engineering the temporomandibular joint disc. , 2008, Acta biomaterialia.

[40]  M. Sadelain,et al.  Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector , 2011, Nature Protocols.

[41]  C. Knudson Hyaluronan and CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly. , 2003, Birth defects research. Part C, Embryo today : reviews.

[42]  Benjamin E. Reubinoff,et al.  Neural progenitors from human embryonic stem cells , 2001, Nature Biotechnology.

[43]  S. Gerson,et al.  Adult bone marrow stem cells for cell and gene therapies: Implications for greater use , 2002, Journal of cellular biochemistry. Supplement.

[44]  V. Fuster,et al.  Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. , 2009, Cellular reprogramming.

[45]  Joel D Stitzel,et al.  Cyclic mechanical preconditioning improves engineered muscle contraction. , 2008, Tissue engineering. Part A.

[46]  Anthony Atala,et al.  Development of a composite vascular scaffolding system that withstands physiological vascular conditions. , 2008, Biomaterials.

[47]  Y. Chong,et al.  Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: A comparative study , 2008, Cell biology international.

[48]  A. Russell,et al.  A Reservoir of Brown Adipocyte Progenitors in Human Skeletal Muscle , 2008, Stem cells.

[49]  F. Gage,et al.  Setting Standards for Human Embryonic Stem Cells , 2003, Science.

[50]  Anthony Atala,et al.  Renal therapy using tissue-engineered constructs and gene delivery , 2000, World Journal of Urology.

[51]  Sara Mantero,et al.  Clinical transplantation of a tissue-engineered airway , 2008, The Lancet.

[52]  Y. Imai,et al.  Transplantation of a tissue-engineered pulmonary artery. , 2001, The New England journal of medicine.

[53]  James J. Yoo,et al.  Bilayered scaffold for engineering cellularized blood vessels. , 2010, Biomaterials.

[54]  T. Ichisaka,et al.  Dental Pulp Cells for Induced Pluripotent Stem Cell Banking , 2010, Journal of dental research.

[55]  M. Weiss,et al.  Concise Review: Wharton's Jelly‐Derived Cells Are a Primitive Stromal Cell Population , 2008, Stem cells.

[56]  G. Morgan,et al.  High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. , 2003, The New England journal of medicine.

[57]  Anthony Atala,et al.  Urine derived cells are a potential source for urological tissue reconstruction. , 2008, The Journal of urology.

[58]  Jakub Tolar,et al.  Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells , 2010, Stem cells.

[59]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[60]  Anthony Atala,et al.  Bioreactors for Development of Tissue Engineered Heart Valves , 2010, Annals of Biomedical Engineering.

[61]  George J Christ,et al.  The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. , 2008, Biomaterials.

[62]  Paolo Carraro,et al.  Isolated Hepatocyte Transplantation for Crigler-Najjar Syndrome Type 1 , 2005, Cell transplantation.

[63]  M. Richards,et al.  Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells , 2002, Nature Biotechnology.

[64]  L. Weiner Definitions and criteria for stem cells. , 2008, Methods in molecular biology.

[65]  T. Muto,et al.  Generation of human induced pluripotent stem cells from oral mucosa. , 2010, Journal of bioscience and bioengineering.

[66]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[67]  P. Menasché,et al.  Cell-based cardiac repair: reflections at the 10-year point. , 2005, Circulation.

[68]  A. Trounson,et al.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro , 2000, Nature Biotechnology.

[69]  D J Mooney,et al.  Injection molding of chondrocyte/alginate constructs in the shape of facial implants. , 2001, Journal of biomedical materials research.

[70]  Zhen W. Zhuang,et al.  Tissue-Engineered Lungs for in Vivo Implantation , 2010, Science.

[71]  D. Loebel,et al.  Allocation and early differentiation of cardiovascular progenitors in the mouse embryo. , 2001, Trends in cardiovascular medicine.

[72]  F. Kuypers,et al.  A BRIEF COMMUNICATION , 2009, Experimental biology and medicine.

[73]  Kathy O. Lui,et al.  Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy. , 2009, Current stem cell research & therapy.

[74]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[75]  W. Zimmermann,et al.  Tissue Engineering of a Differentiated Cardiac Muscle Construct , 2002, Circulation research.

[76]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[77]  C. Gleason,et al.  Time dependent smooth muscle regeneration and maturation in a bladder acellular matrix graft: histological studies and in vivo functional evaluation. , 2001, The Journal of urology.

[78]  Jeffrey A Hubbell,et al.  Materials as morphogenetic guides in tissue engineering. , 2003, Current opinion in biotechnology.

[79]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[80]  James J. Yoo,et al.  Tissue-engineered autologous bladders for patients needing cystoplasty , 2006, The Lancet.

[81]  D. Warburton,et al.  Human Amniotic Fluid Stem Cells Can Integrate and Differentiate into Epithelial Lung Lineages , 2008, Stem cells.

[82]  I. Yannas,et al.  Antigenicity and immunogenicity of collagen. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[83]  M. Schuldiner,et al.  Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers , 1999 .

[84]  Alejandro Soto-Gutiérrez,et al.  Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. , 2009, Gastroenterology.

[85]  A. Atala,et al.  Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. , 1994, The Journal of urology.

[86]  Y. Yoon,et al.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming. , 2011, Antioxidants & redox signaling.

[87]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[88]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[89]  J. Utikal,et al.  Induced Pluripotent Stem Cells Generated Without Viral Integration , 2008, Science.

[90]  B. Stripp,et al.  Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. , 2002, The American journal of pathology.

[91]  F. Claas,et al.  Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. , 2003, Blood.

[92]  A. Ganser,et al.  Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium , 2005, Circulation.

[93]  C. Pillai,et al.  Review Paper: Absorbable Polymeric Surgical Sutures: Chemistry, Production, Properties, Biodegradability, and Performance , 2010, Journal of biomaterials applications.

[94]  Karina H Nakayama,et al.  Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. , 2010, Tissue engineering. Part A.

[95]  Alessandra Giorgetti,et al.  Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. , 2009, Cell stem cell.